Studies have shown that CTRP3 expression can decline in insulin resistance, where treatment with glucagon-like peptide-1 (GLP-1) receptor agonist enhances its expression and improves insulin sensitivity [14]. This evidence concerns the gene C1QTNF3 and Insulin resistance.